These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4581078

  • 1. Lymphocyte anergy in patients with carcinoma.
    Nind AP, Nairn RC, Rolland JM, Guli EP, Hughes ES.
    Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
    [Abstract] [Full Text] [Related]

  • 2. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.
    Flannery GR, Chalmers PJ, Rolland JM, Nairn RC.
    Br J Cancer; 1973 Aug; 28(2):118-22. PubMed ID: 4542343
    [Abstract] [Full Text] [Related]

  • 3. Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
    Pihl E, Nairn RC, Nind AP, Muller HK, Hughes ES, Cuthbertson AM, Rollo AJ.
    Cancer Res; 1976 Oct; 36(10):3665-71. PubMed ID: 1085194
    [Abstract] [Full Text] [Related]

  • 4. Immunological reactivity in patients with carcinoma of colon.
    Nairn RC, Nind AP, Guli EP, Davies DJ, Rolland JM, McGiven AR, Hughes ES.
    Br Med J; 1971 Dec 18; 4(5789):706-9. PubMed ID: 4943033
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA, Kadagidze ZG.
    Vopr Onkol; 1983 Dec 18; 29(12):18-20. PubMed ID: 6607569
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW, Embleton MJ, Price MR.
    Int J Cancer; 1973 Jul 15; 12(1):84-92. PubMed ID: 4790711
    [No Abstract] [Full Text] [Related]

  • 7. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma.
    Werkmeister JA, Pihl E, Flannery GR.
    Aust J Exp Biol Med Sci; 1981 Apr 15; 59(Pt 2):115-24. PubMed ID: 7259635
    [Abstract] [Full Text] [Related]

  • 8. [Assessment of the immunohistological state of the lymph nodes regional to a tumor].
    Serov AA.
    Biull Eksp Biol Med; 1980 Feb 15; 89(2):196-8. PubMed ID: 6966167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
    Ilyin NV, Dexter LI, Bochman YaV.
    Neoplasma; 1979 Feb 15; 26(4):423-7. PubMed ID: 392325
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumours.
    Viac J, Bustamante R, Thivolet J.
    Br J Dermatol; 1977 Jul 15; 97(1):1-10. PubMed ID: 329852
    [Abstract] [Full Text] [Related]

  • 18. Killer cell (K) activity in human normal lymph node, regional tumour lymph node and inflammatory lymph node.
    Eremin O, Ashby J, Franks D.
    Int Arch Allergy Appl Immunol; 1977 Jul 15; 54(3):210-20. PubMed ID: 873621
    [Abstract] [Full Text] [Related]

  • 19. Immunology of human malignant melanoma.
    Lewis MG.
    Ser Haematol; 1972 Jul 15; 5(5):44-65. PubMed ID: 4598040
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.